Loading clinical trials...
Loading clinical trials...
A Phase 2, Open-Label Study of INCB050465 in Participants With Autoimmune Hemolytic Anemia
Conditions
Interventions
Parsaclisib
Locations
12
United States
Georgetown University Hospital
Washington D.C., District of Columbia, United States
University of Minnesota
Minneapolis, Minnesota, United States
Washington University School of Medicine
St Louis, Missouri, United States
Weill Medical College of Cornell University
New York, New York, United States
Montefiore Medical Center
The Bronx, New York, United States
University Health System Inc., Dba the University of Tn Medical Center
Knoxville, Tennessee, United States
Start Date
November 21, 2018
Primary Completion Date
August 5, 2021
Completion Date
April 2, 2024
Last Updated
July 11, 2025
NCT04645199
NCT07361094
NCT07175493
NCT06888960
NCT06921980
NCT04005638
Lead Sponsor
Incyte Corporation
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions